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Abstract: Limbic encephalitis is a multifocal inflammatory disorder
characterized by personality changes, irritability, memory loss, sei-
zures, and, in some cases, dementia. In many cases, it may occur as
a paraneoplastic syndrome and therefore the diagnosis of limbic
encephalitis should raise the possibility of occult malignancy. We
present a case of limbic encephalitis associated with a thymic
carcinoid tumor. To our knowledge the association of thymic car-
cinoid tumor with paraneoplastic limbic encephalitis has not previ-
ously been reported.
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Limbic encephalitis is a multifocal inflammatory disordercharacterized by personality changes, irritability, memory
loss, seizures, and, in some cases, dementia.1 In approxi-
mately 60% of cases, this occurs as a paraneoplastic syn-
drome and has been associated with a number of malignan-
cies, most commonly small cell lung cancer, germ cell tumors
or the testis and breast cancer.2,3 Therefore, following a
diagnosis of limbic encephalitis, the work-up should include
imaging to detect a primary neoplasm including computed
tomography (CT), and cerebrospinal fluid (CSF) examination
for paraneoplastic antibodies.1 With resection and/or appro-
priate therapy for the primary lesion, approximately 30% of
patients show clinical improvement.2 We present a case of
paraneoplastic limbic encephalitis (PLE) associated with a
thymic carcinoid tumor that improved following resection
and adjuvant radiation therapy. To our knowledge, the asso-
ciation of thymic carcinoid tumor with PLE has not previ-
ously been reported.
CASE REPORT
A 59-year-old white man with a past medical history
significant for hypertension presented to the local emergency
department with sudden onset of short term memory lapses
and behavioral changes, including increased aggression, sui-
cidal ideation, and psychomotor agitation all of which began
approximately 2 1⁄2 months before presentation. He had pre-
viously been seen by an outside doctor for a neurologic
workup that was negative, and a psychiatric etiology was
suggested. The patient’s symptoms worsened to the point
where he could not function in society and was being cared
for by his mother. In the emergency department, the patient
initially was aggressive to the point of needing restraints.
Once calm, his physical examination was grossly normal
except that he was not able to follow commands and his
orientation to person place and time could not be assessed.
Current medications included hydrochlorothiazide 25 mg,
Altace 20 mg, aspirin 81 mg, Ortho-Cyclen 20 mg, oxyc-
odone 5 mg as needed, and vitamin B12 100 g.
He was subsequently admitted to the hospital for full
neurologic evaluation. He denied alcohol abuse, smoking or
illicit drug use. Liver function tests were within normal limits
except for slightly elevated alanine aminotransferase at 84
mg/dL (Normal range, 10.0–45.0 mg/dL). CBC, thyroid
function tests and Hemoglobin A1c were all normal, as well
as urinalysis, vitamin B1. Evaluation of CSF revealed a
glucose of 63 mg/dL (normal range, 40–70 mg/dL), slightly
elevated protein of 48 mg/dL (normal range, 15–45 mg/dL),
negative venereal disease research laboratory test, negative
polymerase chain reaction (PCR) for varicella-zoster virus
and cytomegalovirus and negative immunoglobulin G (IgG)
and M for St. Louis encephalitis, Eastern encephalitis, West-
ern encephalitis, and California encephalitis. Further serum
testing for an occult infection including cytomegalovirus,
parvovirus IgG and immunoglobulin M antibodies, herpes
simplex virus PCR, methicillan resistant Staphylococcus au-
reus and vancomycin resistant Enterococcus surveillance cul-
tures, and cryptococcal antigen test were all negative. CT and
magnetic resonance (MR) of the brain with and without
contrast were essentially normal for age. A subsequent nu-
clear medicine brain single photon emission CT scan with
technetium 99m hexamethylpropylene amine oxime (Neuro-
lite, Bristol-Myers Squibb, North Bellerica, MA) revealed
asymmetric perfusion with relative hypoperfusion of the right
cerebral hemisphere (Figure 1A) and a clinical diagnosis of
limbic encephalitis was made.
During this time, the patient continued to show aggres-
sive behavior and inhibition difficulties, including foul lan-
guage towards the hospital staff and he was transferred to
Psychiatry for evaluation of a cognitive disorder. Prior to ad-
mission to psychiatry, a chest radiograph was obtained to
exclude disease that would make the patient medically unfit
for the psychiatry ward. The chest radiograph revealed an
anterior mediastinal mass projecting over the left hilum
(Figure 1B) and a subsequent CT with contrast (Figure 1C)
Department of Radiology, Medical University of South Carolina, Charleston,
South Carolina.
Disclosure: The authors declare no conflicts of interest.
Address for correspondence: James G. Ravenel, MD, Department of Radi-
ology, Medical University of South Carolina, Box 250322, 169 Ashley
Ave, Charleston, SC 29425. E-mail: ravenejg@musc.edu
Copyright © 2008 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/08/0312-1484
Journal of Thoracic Oncology • Volume 3, Number 12, December 20081484
revealed a 6.2 5.9 cm heterogeneous mass with serpiginous
vessels centrally in the anterior mediastinum. Based on
known associations and the appearance of the mass, a pre-
sumptive diagnosis of thymoma was made. The patient un-
derwent a median sternotomy and thymectomy revealing a 6
cm mass in the thymus without invasion of adjacent struc-
tures. Pathology of the tumor showed atypical carcinoid
tumor of the thymus. A paraneoplastic antibody evaluation
panel was done after surgery which revealed negative results
for the following: antineuronal nuclear antibody type 1 (anti
Hu), 2 and 3, purkinje cell cytoplasmic antibody type 1, 2,
and T, Amphiphysin antibody, collapsin response-mediator
protein 5 IgG, striational (striated muscle) antibody, P/Q type
calcium channel antibody, N-type calcium channel antibody,
ACh receptor (muscle) binding antibody, AChR ganglionic
neuronal antibody, Anti-MA1, Anti-MA2, and voltage-gated
potassium channel antibody. In the immediaste postoperative
period, his mental status steadily improved both subjectively
and objectively with improved memory and demeanor. Now
9 months since his operation, the patient has returned to his
normal baseline emotionally but still experiences residual
amnestic episodes.
DISCUSSION
Limbic encephalitis is a multifocal inflammatory dis-
order, that is due to a neoplastic process in up to 60% of
cases.1 Although generally rare, paraneoplastic neurologic
syndromes can be an important key to diagnosing cancer in a
patient, predating the diagnosis of malignancy by an average
of 3 to 5 months.3 Most commonly, these result from an
autoimmune reaction to onconeural antigens including an-
tineuronal nuclear antibody type 1 (anti-Hu) antibodies
strongly associated with small cell lung cancer and anti-Ma2
antibodies associated with testicular and ovarian germ cell
tumors.2 Diagnosis therefore includes CSF examination for a
complete cell count, protein, glucose, oligoclonal bands, IgG
synthesis rate, cytology, and PCR for herpes simplex virus
and varicella zoster virus as well as clinical and neuropsy-
chiatric features. In up to 40% of cases, however, auto-
antibodies may be atypical or absent in the CSF and these
cases seem to be associated with a wider variety of neo-
plasms.2 In the current case a battery of known paraneoplastic
antibodies were tested and were all negative.
Limbic encephalitis can present with an array of per-
sonality changes, including irritability, hallucinations, sei-
zures, and memory loss. A significant number of patients with
limbic encephalitis have MR imaging T2 and focal fluid-
attenuated inversion recovery hyperintensities involving one
or both medial temporal lobes.4 Positron emission tomogra-
phy studies usually show radionuclide uptake in the temporal
lobes.5 It should, however, be noted that MR studies can be
normal in 20 to 30% of cases and in PLE the imaging findings
in the brain can be remote from the limbic system.1 PLE may
respond to medical or surgical treatment of the tumor. As in
our case, about 30% of patients will show improvement with
treatment of the tumor.6
In the current case, thymic carcinoid was the cause, a
tumor previously not associated with PLE. While thymic
FIGURE 1. A 59-year-old man
with paraneoplastic limbic enceph-
alitis due to thymic carcinoid. A,
Composite of axial single photon
emission computed tomography
(SPECT) images from technetium-
99m-hexamethylpropylene amine
oxime (HMPAO) study reveals nor-
mal uptake the left cerebral hemi-
sphere and decreased uptake to
the right temporal and parietal
lobes. B, Frontal chest radiograph
reveals anterior mediastinal mass
projecting over the left hilum and
A-P window (arrow). C, Axial com-
puted tomography (CT) images
with contrast reveal heterogeneous
anterior mediastinal mass (arrow)
with enlarged central vessels.
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carcinoid tumors may be clinically silent, it is relatively
common for them to be associated with paraneoplastic syn-
dromes including Cushing syndrome and multiple endocrine
neoplasia while neurologic paraneoplastic syndromes are dis-
tinctly unusual.7 Similarly, there is a wide spectrum of ag-
gressiveness, about 80% of cases show aggressive behavior
with local recurrence and metastasis.7
Thymic carcinoid tumors arise from the neuroendocrine
thymic cells located in the anterior mediastinum and are rare
malignant tumors that accounts for approximately 2 to 4% of
anterior mediastinal neoplasms.7,8 Radiographically, these
lesions are seen as large anterior mediastinal masses. On CT
and magnetic resonance imaging this tumor usually presents
as a soft-tissue mass in the anterior mediastinum with heter-
ogeneous contrast enhancement. The lesion can consist of
calcifications or necrosis and be localized or invasive.7 The
differential diagnosis includes other causes of anterior medi-
astinal masses: thymoma, thymic carcinoma, lymphoma, and
germ cell neoplasms, all of which have been previously
associated with PLE.
In summary, limbic encephalitis is a relatively rare
paraneoplastic syndrome that is often associated with thoracic
neoplasms. As our case demonstrates, thymic carcinoid tu-
mors can now be added to the list of neoplasms that may be
heralded by PLE.
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